Biomarkers Market Size Worth USD 88,605.25 Million by 2030 at 10.80% CAGR - Report by Market Research Future (MRFR)
28 oct. 2022 09h30 HE
|
Market Research Future
New York, USA, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Biomarkers Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biomarkers Market Information by...
Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy
12 juil. 2022 11h01 HE
|
Elixiron Immunotherapeutics
SAN FRANCISCO, July 12, 2022 (GLOBE NEWSWIRE) -- Elixiron Immunotherapeutics, a clinical stage drug development company announced today that it has received a new grant from the Alzheimer's...
North America DNA Sequencing Market Anticipated to Garner a Revenue of $9,154 million and Grow at a Healthy CAGR of 15.9% during the Estimated Timeframe from 2019 to 2025 [200-Pages] | Revealed by Research Dive
28 juin 2022 09h00 HE
|
Research Dive
New York, USA, June 28, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the North America DNA Sequencing Market is envisioned to generate a revenue of $9,154 million and...
Global Digital Biomarkers Market is set to witness a significant CAGR of 35% from 2021 to 2026
16 mai 2022 09h30 HE
|
Medi-Tech Insights
Brussels, Belgium, May 16, 2022 (GLOBE NEWSWIRE) -- Description: Digital biomarkers are indexes that use data from digital platforms such as smartphones and wearable devices to objectively...
Standard BioTools Announces First Quarter 2022 Financial Results
05 mai 2022 16h02 HE
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today...
Neuronascent Releases Further Positive Results of NNI-362 in A Randomized Phase 1a Trial for Alzheimer’s Disease
30 mars 2022 06h00 HE
|
Neuronascent, Inc.
ROCKVILLE, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., is a clinical-stage pharmaceutical company discovering and developing novel regenerative therapies for age-related brain...
Biomarkers In Cancer Targeted Immunotherapy
15 mars 2022 03h53 HE
|
KuicK Research
Delhi, March 15, 2022 (GLOBE NEWSWIRE) -- Global Breast Cancer Antibodies Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Breast Cancer Antibodies Market Opportunity:...
Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022
10 mars 2022 07h30 HE
|
Cognition Therapeutics, Inc.
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage neuroscience company developing drugs that treat age-related degenerative diseases of the...
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results
17 févr. 2022 17h43 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
04 janv. 2022 08h33 HE
|
Inotiv, Inc.
-- Expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions -- -- Expected to enhance scale, broaden customer base...